Scientific consulting firm Exponent (NASDAQ:EXPO) announced in Q3 CY2025, with sales up 17.6% year on year to $147.1 million.

In a world where change is not only a constant but also rapidly accelerating, conventional thought patterns are not merely insufficient—they're risky. As an innovation expert, I've observed that the ...

Q3 2025 Earnings Call Transcript October 30, 2025 Exponent, Inc. beats earnings expectations. Reported EPS is $0.55, ...

Exponent is returning to a 13-week fiscal fourth quarter in 2025, which poses a headwind for comparisons since Q4 of fiscal 2024 benefited from a 14th week. For the fourth quarter of fiscal 2025 as ...